Sentences with phrase «dendritic cell treatment»

As these authors from Biopharm Serfices and Biopharm Designs show, varying overall process failure rates significantly affects the per - patient cost of a dendritic cell treatment.

Not exact matches

«These results represent a significant advance in our understanding of how commensal microbes can regulate host intestinal immune responses and suggest that the identification of downstream targets in macrophages and dendritic cells along the GM - CSF axis can help the rationale design of novel strategies for the treatment of IBD patients with defective GM - CSF function,» explained Dr. Merad.
Both memory T cells subtypes can be reactivated with current immunotherapy treatments, and reactivation of both requires DC1 dendritic cells.
Rather than round up a patient's T cells and re-engineer them in a lab to find cancer, this treatment harvests a class of immune «helpers» called dendritic cells.
Tanyi said he is eager to explore whether the dendritic - cell vaccine might also be used as a first - line treatment for women who are newly diagnosed with ovarian cancer.
«Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123 - Specific CAR T Cells: A First - in - Human Clinical Trial» is presented at the ASH Annual Meeting Dec. 9 to 12, 2017.
«It also suggests we could develop ways to help patients who don't initially respond to immune - mediated treatment, such as direct injection of their own CD103 + dendritic cells.
This treatment represents a second generation approach to the same telomerase loaded, dendritic cell vaccination immunotherapy strategy that has been tested in two previous clinical trials of our AST - VAC1 product.
He is currently funded (2016 - 2021) by the National Cancer Institute to study radiation induced changes in neuron cell dendritic morphology in cancer treatment with X-rays, protons and carbon beams, and has received grants from the Department of Energy and NASA in the past.
Immune Design is a clinical - stage biotechnology company made up of collaborative, «can do», experienced professionals passionate about leveraging the company's leading - edge technologies that target dendritic cells for a more precise immune response for the treatment of cancer and other chronic conditions.
Here, Dr. Tam presents data characterizing the intracellular signaling pathway associated with the RANK — RANKL axis, as well as the effect in dendritic cells, antigen - specific T cells, cytokines, and chemokine profiles after in vivo treatment with blocking PD - L1 and T cell - depleting antibodies in a melanoma cancer model.
a b c d e f g h i j k l m n o p q r s t u v w x y z